#BEGIN_DRUGCARD DB02658

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C12H13FN2O9

# Chemical_IUPAC_Name:
(2R,3S,4S,5R,6S)-6-(2,4-dinitrophenoxy)-5-fluoro-2-(hydroxymethyl)oxane-3,4-diol

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Beta-Glucosidase A Inhibitors

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside

# HET_ID:
NFG

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C12H13FN2O9/c13-9-11(18)10(17)8(4-16)24-12(9)23-7-2-1-5(14(19)20)3-6(7)15(21)22/h1-3,8-12,16-18H,4H2/t8-,9-,10-,11-,12-/m1/s1

# InChI_Key:
InChIKey=UFSBFVZQJZMIOU-LZQZFOIKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2658

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
348.238

# Molecular_Weight_Mono:
348.060508229

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1UYQ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
0.38

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
1.48e+00 g/l

# Primary_Accession_No:
DB02658

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
445227

# PubChem_Substance_ID:
46508582

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02330

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@]1(CO)O[C@@]([H])(OC2=C(C=C(C=C2)[N+]([O-])=O)[N+]([O-])=O)[C@]([H])(F)[C@@]([H])(O)[C@]1([H])O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M60210

# Drug_Target_1_GenBank_ID_Protein:
142580

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
bglA

# Drug_Target_1_Gene_Sequence:
>1347 bp
ATGACTATTTTTCAATTTCCGCAGGACTTTATGTGGGGTACCGCAACGGCCGCCTACCAA
ATCGAGGGGGCTTACCAGGAGGATGGAAGAGGGTTGTCGATCTGGGATACCTTTGCCCAT
ACGCCTGGCAAAGTGTTCAACGGTGACAACGGCAATGTAGCTTGTGACAGCTATCATCGT
TACGAAGAAGATATCCGTCTCATGAAGGAACTGGGCATTCGTACATATCGTTTCTCGGTG
TCCTGGCCACGTATATTCCCTAATGGTGATGGTGAAGTCAATCAAGAGGGATTGGACTAT
TATCATCGTGTAGTTGATTTGTTGAATGACAACGGAATTGAACCGTTTTGTACACTGTAT
CACTGGGATCTGCCTCAGGCGCTACAGGATGCCGGAGGATGGGGAAATCGTCGCACAATT
CAGGCATTTGTCCAGTTTGCGGAAACGATGTTCCGTGAGTTTCACGGTAAAATACAGCAT
TGGCTGACATTCAATGAACCGTGGTGTATCGCCTTTTTATCCAATATGCTGGGAGTTCAT
GCCCCGGGTCTGACGAATCTCCAGACTGCGATTGATGTAGGACATCATCTGCTGGTTGCG
CATGGCCTATCTGTACGCCGATTCCGCGAGCTTGGCACCAGTGGCCAGATCGGTATCGCC
CCAAATGTCTCCTGGGCTGTTCCTTACAGCACTTCTGAGGAAGATAAAGCGGCTTGTGCA
CGCACGATTTCCCTGCACAGTGACTGGTTTCTCCAGCCTATTTATCAAGGCTCGTATCCT
CAGTTTTTGGTAGACTGGTTTGCGGAACAGGGAGCCACCGTACCTATACAAGATGGAGAT
ATGGACATTATCGGTGAGCCAATTGATATGATTGGTATCAATTATTATAGTATGTCGGTT
AATCGATTTAATCCGGAGGCAGGATTTCTTCAATCTGAAGAAATCAATATGGGACTACCT
GTAACAGATATCGGCTGGCCGGTGGAGTCACGTGGGCTGTATGAGGTACTACATTATTTG
CAAAAATACGGTAACATCGATATTTACATCACAGAGAACGGGGCTTGTATCAATGATGAG
GTCGTAAACGGAAAGGTGCAAGATGATCGTCGAATTTCCTACATGCAGCAGCATTTGGTG
CAGGTGCACCGGACAATTCATGATGGTCTTCATGTTAAAGGCTATATGGCATGGTCACTT
TTGGACAATTTTGAGTGGGCAGAGGGGTATAATATGAGATTTGGCATGATTCATGTCGAT
TTTCGCACACAGGTCCGCACCCCCAAGGAAAGTTACTATTGGTATCGAAATGTAGTAAGT
AATAACTGGTTGGAGACTAGACGCTAA

# Drug_Target_1_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_1_General_References:
2123813	Gonzalez-Candelas L, Ramon D, Polaina J: Sequences and homology analysis of two genes encoding beta-glucosidases from Bacillus polymyxa. Gene. 1990 Oct 30;95(1):31-8.
9466926	Sanz-Aparicio J, Hermoso JA, Martinez-Ripoll M, Lequerica JL, Polaina J: Crystal structure of beta-glucosidase A from Bacillus polymyxa: insights into the catalytic activity in family 1 glycosyl hydrolases. J Mol Biol. 1998 Jan 23;275(3):491-502.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3289

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
51650

# Drug_Target_1_Name:
Beta-glucosidase A

# Drug_Target_1_Number_of_Residues:
448

# Drug_Target_1_PDB_ID:
1BGG

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00232	Glyco_hydro_1

# Drug_Target_1_Protein_Sequence:
>Beta-glucosidase A
MTIFQFPQDFMWGTATAAYQIEGAYQEDGRGLSIWDTFAHTPGKVFNGDNGNVACDSYHR
YEEDIRLMKELGIRTYRFSVSWPRIFPNGDGEVNQEGLDYYHRVVDLLNDNGIEPFCTLY
HWDLPQALQDAGGWGNRRTIQAFVQFAETMFREFHGKIQHWLTFNEPWCIAFLSNMLGVH
APGLTNLQTAIDVGHHLLVAHGLSVRRFRELGTSGQIGIAPNVSWAVPYSTSEEDKAACA
RTISLHSDWFLQPIYQGSYPQFLVDWFAEQGATVPIQDGDMDIIGEPIDMIGINYYSMSV
NRFNPEAGFLQSEEINMGLPVTDIGWPVESRGLYEVLHYLQKYGNIDIYITENGACINDE
VVNGKVQDDRRISYMQQHLVQVHRTIHDGLHVKGYMAWSLLDNFEWAEGYNMRFGMIHVD
FRTQVRTPKESYYWYRNVVSNNWLETRR

# Drug_Target_1_Reaction:
Hydrolysis of terminal, non-reducing beta-D-glucose residues with release of beta-D-glucose ALL_REAC (other) R00026 R02887 R03527 R04949 R04998 R06077(G) R06092(G)

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
BglA is intracellular and cleaves cellobiose probably through inorganic phosphate mediated hydrolysis

# Drug_Target_1_SwissProt_ID:
P22073

# Drug_Target_1_SwissProt_Name:
BGLA_PAEPO

# Drug_Target_1_Synonyms:
Amygdalase
BGA
Beta-D- glucoside glucohydrolase
Cellobiase
EC 3.2.1.21
Gentiobiase

# Drug_Target_1_Theoretical_pI:
4.97

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02658
